Clinical trial
A French Post-market Observational/Non-interventional Study of the BioMatrix Flex™ and BioMatrix Neo Flex™ Drug Eluting Stents With 6-month DAPT
NCT03461484 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A French Post-market Observational/Non-interventional Study of the BioMatrix Flex™ and BioMatrix Neo Flex™ Drug Eluting Stents With 6-month DAPT
- Lead sponsor
- Biosensors Europe SA
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 6, 2014
- Completion date
- October 31, 2019
- Enrollment
- 2,098 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery stenoses, ischemia, nstemi - non-st segment elevation mi, stable angina, stemi